Multicellular Tumor Spheroids for Evaluation of Cytotoxicity and Tumor Growth Inhibitory Effects of Nanomedicines In Vitro: A Comparison of Docetaxel-Loaded Block Copolymer Micelles and Taxotere®

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Mikhail, Andrew S ^a,b   Eetezadi, Sina ^a   Allen, Christine ^a,b,c  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c Innovation Centre   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

COPOLYMER; DOCETAXEL; ANTINEOPLASTIC AGENT; MICELLE; POLYMER; TAXOID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL; CANCER INHIBITION; COLON CANCER; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG EFFICACY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MICELLE; MOUSE; MULTICELLULAR SPHEROID; NANOMEDICINE; NONHUMAN; TREATMENT RESPONSE; TUMOR GROWTH; TUMOR MICROENVIRONMENT; TUMOR SPHEROID; UTERINE CERVIX CANCER; CELL PROLIFERATION; CHEMISTRY; DRUG SCREENING; PARTICLE SIZE; TOXICITY; TUMOR CELL CULTURE; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CELL PROLIFERATION; DRUG DELIVERY SYSTEMS; HUMANS; MICELLES; NANOMEDICINE; PARTICLE SIZE; POLYMERS; SPHEROIDS, CELLULAR; TAXOIDS; TUMOR CELLS, CULTURED; TUMOR STEM CELL ASSAY;

EID: 84876590359     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0062630     Document Type: Article

References (53)

1. Trédan O, Galmarini CM, Patel K, Tannock IF, (2007) Drug resistance and the solid tumor microenvironment. J Natl Cancer Inst 99: 1441-1454.
2. Swartz MA, Iida N, Roberts EW, (2012) Tumor Microenvironment Complexity: Emerging Roles in Cancer Therapy. Cancer Res 72: 2473-2480.
3. Jain RK, Stylianopoulos T, (2010) Delivering nanomedicine to solid tumors. Nat Rev Clin Oncol 7: 653-664.
4. Minchinton AI, Tannock IF, (2006) Drug penetration in solid tumours. Nat Rev Cancer 6: 583-592.
5. Vaupel P, Mayer A, (2007) Hypoxia in cancer: significance and impact on clinical outcome. Cancer Metastasis Rev 26: 225-239.
6. Kim JW, Ho WJ, Wu BM, (2011) The role of the 3D environment in hypoxia-induced drug and apoptosis resistance. Anticancer Res 31: 3237-3245.
7. Chauhan VP, Stylianopoulos T, Boucher Y, Jain RK, (2011) Delivery of Molecular and Nanoscale Medicine to Tumors: Transport Barriers and Strategies. Annu Rev Chem Biomol Eng 2: 281-298.
8. Johnson JI, Decker S, Zaharevitz D, Rubinstein L V, Venditti JM, et al. (2001) Relationships between drug activity in NCI preclinical in vitro and in vivo models and early clinical trials. Br J Cancer 84: 1424-1431.
9. Phillips R, Bibby M, Double J, (1990) A Critical Appraisal of the Predictive Value of in Vitro Chemosensitivity Assays. J Natl Cancer Inst 82: 1457-1463.
10. Elliott N, (2010) A review of three-dimensional in vitro tissue models for drug discovery and transport studies. J Pharm Sci 100: 2-8.
11. Nyga A, Cheema U, Loizidou M, (2011) 3D tumour models: novel in vitro approaches to cancer studies. J Cell Commun Signal 5: 239-248.
12. Vinci M, Gowan S, Boxall F, Patterson L, Zimmermann M, et al. (2012) Advances in establishment and analysis of 3D tumour spheroid-based functional assays for target validation and drug evaluation. BMC Biol 10: 1-20.
13. Rotin D, Robinson B, Tannock IF, (1986) Influence of hypoxia and an acidic environment on the metabolism and viability of cultured cells: potential implications for cell death in tumors. Cancer Res 46: 2821-2826.
14. Nederman T, Norling B, Glimelius B, Carlsson J, Brunk U, (1984) Demonstration of an Extracellular Matrix in Multicellular Tumor Spheroids. Cancer Res 44: 3090-3097.
15. Acker H, Carlsson J, Mueller-Klieser W, Sutherland RM, (1987) Comparative pO2 measurements in cell spheroids cultured with different techniques. Br J Cancer 56: 325-327.
16. Fischbach C, Chen R, Matsumoto T, Schmelzle T, Brugge JS, et al. (2007) Engineering tumors with 3D scaffolds. Nat Methods 4: 6-11.
17. Horning JL, Sahoo SK, Vijayaraghavalu S, Dimitrijevic S, Vasir JK, et al. (2008) 3-D tumor model for in vitro evaluation of anticancer drugs. Mol Pharm 5: 849-862.
18. Hicks KO, Ohms SJ, Van Zijl PL, Denny WA, Hunter PJ, et al. (1997) An experimental and mathematical model for the extravascular transport of a DNA intercalator in tumours. Br J Cancer 76: 894-903.
19. Tannock IF, Lee CM, Tunggal JK, Cowan DSM, Egorin MJ, (2002) Limited penetration of anticancer drugs through tumor tissue: a potential cause of resistance of solid tumors to chemotherapy. Clinical cancer research: an official journal of the American Association for Cancer Res 8: 878-884.
20. Cowan DS, Tannock IF, (2001) Factors that influence the penetration of methotrexate through solid tissue. Int J Cancer 91: 120-125.
21. Chetprayoon P, Kadowaki K, Matsusaki M, Akashi M (2012) Survival and structural evaluations of three-dimensional tissues fabricated by the hierarchical cell manipulation technique. Acta Biomater in press.
22. Hosoya H, Kadowaki K, Matsusaki M, Cabral H, Nishihara H, et al. (2012) Engineering fibrotic tissue in pancreatic cancer: A novel three-dimensional model to investigate nanoparticle delivery. Biochem Biophys Res Commun 419: 32-37.
23. Grantab R, Sivananthan S, Tannock IF, (2006) The penetration of anticancer drugs through tumor tissue as a function of cellular adhesion and packing density of tumor cells. Cancer Res 66: 1033-1039.
24. Hirschhaeuser F, Menne H, Dittfeld C, West J, Mueller-Klieser W, et al. (2010) Multicellular tumor spheroids: an underestimated tool is catching up again. J Biotechnol 148: 3-15.
25. Kim T-H, Mount CW, Gombotz WR, Pun SH, (2010) The delivery of doxorubicin to 3-D multicellular spheroids and tumors in a murine xenograft model using tumor-penetrating triblock polymeric micelles. Biomaterials 31: 7386-7397.
26. Perche F, Patel NR, Torchilin VP (2012) Accumulation and toxicity of antibody-targeted doxorubicin-loaded PEG-PE micelles in ovarian cancer cell spheroid model. J Control Release in press.
27. Oishi M, Nagasaki Y, Nishiyama N, Itaka K, Takagi M, et al. (2007) Enhanced growth inhibition of hepatic multicellular tumor spheroids by lactosylated poly(ethylene glycol)-siRNA conjugate formulated in PEGylated polyplexes. ChemMedChem 2: 1290-1297.
28. Tsukioka Y, Matsumura Y, Hamaguchi T, Koike H, Moriyasu F, et al. (2002) Pharmaceutical and biomedical differences between micellar doxorubicin (NK911) and liposomal doxorubicin (Doxil). Jpn J Cancer Res 93: 1145-1153.
29. Bae Y, Nishiyama N, Fukushima S, Koyama H, Yasuhiro M, et al. (2005) Preparation and biological characterization of polymeric micelle drug carriers with intracellular pH-triggered drug release property: tumor permeability, controlled subcellular drug distribution, and enhanced in vivo antitumor efficacy. Bioconjug Chem 16: 122-130.
30. Prescribing Information, Taxotere (2010). Sanofi-Aventis. Available: http://products.sanofi.us/Taxotere/taxotere.html.
31. ClinicalTrials.gov. Available: http://clinicaltrials.gov/ct2/show/NCT01639131?term=colonanddocetaxel&rank=15. Accessed 2013 March 18.
32. ClinicalTrials.gov. Available: http://clinicaltrials.gov/ct2/show/NCT00003445?term=cervixanddocetaxel&rank=3. Accessed 2013 March 18.
33. Baur M, Van Oosterom AT, Diéras V, Tubiana-Hulin M, Coombes RC, et al. (2008) A phase II trial of docetaxel (Taxotere) as second-line chemotherapy in patients with metastatic breast cancer. J Cancer Res Clin Oncol 134: 125-135.
34. Mikhail A, Allen C, (2009) Block copolymer micelles for delivery of cancer therapy: transport at the whole body, tissue and cellular levels. J Control Release 138: 214-223.
35. Mikhail A, Allen C, (2010) Poly(ethylene glycol)-b-poly(epsilon-caprolactone) micelles containing chemically conjugated and physically entrapped docetaxel: synthesis, characterization, and the influence of the drug on micelle morphology. Biomacromolecules 11: 1273-1280.
36. Zahedi P, Stewart J, De Souza R, Piquette-Miller M, Allen C, (2012) An injectable depot system for sustained intraperitoneal chemotherapy of ovarian cancer results in favorable drug distribution at the whole body, peritoneal and intratumoral levels. J Control Release 158: 379-385.
37. Marusić M, Bajzer Z, Freyer JP, Vuk-Pavlović S, (1994) Analysis of growth of multicellular tumour spheroids by mathematical models. Cell Prolif 27: 73-94.
38. Friedrich J, Eder W, Castaneda J, Doss M, Huber E, et al. (2007) A reliable tool to determine cell viability in complex 3-d culture: the acid phosphatase assay. J Biomol Screen 12: 925-937.
39. Joyce J a, Pollard JW, (2009) Microenvironmental regulation of metastasis. Nat Rev Cancer 9: 239-252.
40. Hanahan D, Weinberg R a, (2011) Hallmarks of cancer: the next generation. Cell 144: 646-674.
41. Okubo H, Matsushita M, Kamachi H, Kawai T, Takahashi M, et al. (2002) A novel method for faster formation of rat liver cell spheroids. Artif Organs 26: 497-505.
42. Del Duca D, Werbowetski T, Del Maestro RF, (2004) Spheroid preparation from hanging drops: characterization of a model of brain tumor invasion. J Neurooncol 67: 295-303.
43. Friedrich J, Seidel C, Ebner R, Kunz-Schughart L a, (2009) Spheroid-based drug screen: considerations and practical approach. Nat Protoc 4: 309-324.
44. Hardelauf H, Frimat J-P, Stewart JD, Schormann W, Chiang Y-Y, et al. (2011) Microarrays for the scalable production of metabolically relevant tumour spheroids: a tool for modulating chemosensitivity traits. Lab Chip 11: 419-428.
45. Ong S-M, Zhao Z, Arooz T, Zhao D, Zhang S, et al. (2010) Engineering a scaffold-free 3D tumor model for in vitro drug penetration studies. Biomaterials 31: 1180-1190.
46. Kyle AH, Huxham L a, Yeoman DM, Minchinton AI, (2007) Limited tissue penetration of taxanes: a mechanism for resistance in solid tumors. Clin Cancer Res 13: 2804-2810.
47. Han M, Oba M, Nishiyama N, Kano MR, Kizaka-Kondoh S, et al. (2009) Enhanced percolation and gene expression in tumor hypoxia by PEGylated polyplex micelles. Mol Ther 17: 1404-1410.
48. Fonseca C, Simões S, Gaspar R, (2002) Paclitaxel-loaded PLGA nanoparticles: preparation, physicochemical characterization and in vitro anti-tumoral activity. J Control Release 83: 273-286.
49. Nemati F, Dubernet C, Poupon M, Couvreur P (1996) Reversion of multidrug resistance using nanoparticles in vitro: influence of the nature of the polymer. Int J Pharm: 237-246.
50. Cavallaro G, Fresta M, Giammona G, Puglisi G, Villari A, (1994) Entrapment of B-lactams antibiotics in polyethylcyanoacrylate nanoparticles: Studies on the possible in vivo application of this colloidal delivery system. Int J Pharm 111: 31-41.
51. Panyam J, Labhasetwar V, (2003) Dynamics of endocytosis and exocytosis of poly(D,L-lactide-co-glycolide) nanoparticles in vascular smooth muscle cells. Pharm Res 20: 212-220.
52. Yoo HS, Park TG, (2004) Folate-receptor-targeted delivery of doxorubicin nano-aggregates stabilized by doxorubicin-PEG-folate conjugate. J Control Release 100: 247-256.
53. Yoo HS, Park TG, (2004) Folate receptor targeted biodegradable polymeric doxorubicin micelles. J Control Release 96: 273-283.